Sluggish FUS: a key for HSC aging
Open Access
- 11 January 2024
- journal article
- editorial
- Published by American Society of Hematology in Blood
- Vol. 143 (2) , 99-100
Abstract
In this issue of Blood, Tang and colleagues report that the RNA-binding protein fused in sarcoma (FUS) is a newly identified effector of hematopoietic stem cellKeywords
This publication has 10 references indexed in Scilit:
- Aging-disturbed FUS phase transition impairs hematopoietic stem cells by altering chromatin structureBlood, 2024
- Hematopoietic stem cell aging and leukemia transformationBlood, 2023
- The RGG motif proteins: Interactions, functions, and regulationsWIREs RNA, 2022
- Aged hematopoietic stem cells are refractory to bloodborne systemic rejuvenation interventionsJournal of Experimental Medicine, 2021
- Decline in IGF1 in the bone marrow microenvironment initiates hematopoietic stem cell agingCell Stem Cell, 2021
- Mitochondrial Potentiation Ameliorates Age-Related Heterogeneity in Hematopoietic Stem Cell FunctionCell Stem Cell, 2021
- Limited rejuvenation of aged hematopoietic stem cells in young bone marrow nicheJournal of Experimental Medicine, 2020
- Liquid Nuclear Condensates Mechanically Sense and Restructure the GenomeCell, 2018
- Formation and Maturation of Phase-Separated Liquid Droplets by RNA-Binding ProteinsMolecular Cell, 2015
- Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansionProceedings of the National Academy of Sciences, 2010